Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LogicBio Therapeutics Inc
LOGC | US
6.29
USD0.22
3.62%
LOGC | US
About LogicBio Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
6.29
Open
6.06
High
6.34
Low
6.03
View Less
LOGC | US
Risk
29.5
Sharpe
0
Luna's Score
49/100
Recommendation
Hold
Luna says (LOGC | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low 6-Month Volatility (<30%)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
29.4%1 month
29.5%3 months
28.7%6 months
27.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.02
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.99
Ent. to rev.
0.05
PEG
-
Other Fundamentals
EBITDA
-207.00M
MarketCap
165.27M
MarketCap(USD)
165.27M
Div. yield
-
Op. margin
-271.43
Erngs. growth
-
Rev. growth
-91.00
Ret. on equity
-89.61
Short ratio
11.89
Short perc.
10.30
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.74
Range1M
1.15
Range3M
1.42
Volumes: Market Activity
Rel. volume
1.51
Price X volume
2.54M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.99 | 0.53 | Expensive |
| Ent. to Revenue | 0.05 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.02 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 28.69 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 165.27M | 3.66B | Emerging |
